Next we hypothesized that FGF1 may have similar effects to suppress the HPA axis resulting in lower rates of whole-body lipolysis, hepatic acetyl CoA and hepatic glucose production in insulinopenic T1D rodents. Here, FGF1 is linked to type 1 diabetes mellitus.